Coralien H. Vink
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.
Journal: Kidney medicine
Published: January 09, 2026
Sensitivity of Enzyme-Linked Immunosorbent Assay in Monitoring Treatment Response in Phospholipase A2 Receptor -Associated Membranous Nephropathy.
Journal: Kidney international reports
Published: April 25, 2025
Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy.
Journal: Kidney international reports
Published: June 27, 2024
C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy.
Journal: JCI insight
Published: June 09, 2023
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy.
Journal: Kidney international reports
Published: July 03, 2022
COVID-19 Vaccination in Patients With Membranous Nephropathy.
Journal: Kidney international reports
Published: May 21, 2022
Daratumumab for multidrug-resistant phospholipase-A2 receptor-related membranous nephropathy.
Journal: Kidney international
Published: November 16, 2021
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.
Journal: Kidney international reports
Published: July 09, 2020
The bias between different albumin assays may affect clinical decision-making.
Journal: Kidney international
Published: June 07, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026